| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | Leite John Global Chief Commercial Off | Sale | -13,975 | -9.55%132,305 | $50.07 | $699,732 | View SEC filing | |
| 2026-06-04 | McGuire Annie EVP, General Counsel | Sale | -3,176 | -2.26%137,240 | $49.76 | $158,036 | View SEC filing | |
| 2026-06-04 | Chambers Rebecca Chief Financial Officer | Sale | -3,561 | -2.01%173,280 | $49.73 | $177,083 | View SEC filing | |
| 2026-06-04 | Stapley Marc Chief Executive Officer | Sale | -138,051 | -23.86%440,494 | $50.12 | $6,919,585 | View SEC filing | |
| 2026-05-27 | Wygant Jonathan VP, Chief Accounting Officer | Sale | -24,000 | -34.57%45,434 | $45.40 | $1,089,624 | View SEC filing | |
| 2026-05-22 | EPSTEIN ROBERT S Director | Sale | -10,000 | -16.01%52,446 | $44.01 | $440,129 | View SEC filing | |
| 2026-05-08 | McGuire Annie SVP, General Counsel | Sale | -10,204 | -6.63%143,708 | $39.02 | $398,211 | View SEC filing | |
| 2026-03-06 | Leite John Chief Commercial Officer-CLIA | Sale | -5,260 | -4.66%107,580 | $35.19 | $185,083 | View SEC filing | |
| 2026-03-06 | McGuire Annie SVP, General Counsel | Sale | -6,658 | -6.57%94,706 | $35.55 | $236,725 | View SEC filing | |
| 2026-03-06 | Chambers Rebecca Chief Financial Officer | Sale | -18,341 | -12.27%131,196 | $36.14 | $662,869 | View SEC filing | |
| 2026-03-06 | Stapley Marc Chief Executive Officer | Sale | -45,523 | -11.29%357,554 | $35.97 | $1,637,594 | View SEC filing | |
| 2026-03-04 | Febbo Phillip G. Chief Scientific & Med Officer | Sale | -13,425 | -10.27%117,346 | $36.16 | $485,429 | View SEC filing | |
| 2025-12-17 | McGuire Annie SVP, General Counsel | Sale | -10,739 | -13.68%67,760 | $43.13 | $463,204 | View SEC filing | |
| 2025-12-08 | EASTHAM KARIN Director | Sale | -20,000 | -59.61%13,554 | $45.45 | $908,923 | View SEC filing | |
| 2025-12-04 | Leite John Chief Commercial Officer-CLIA | Sale | -1,278 | -1.53%82,113 | $47.51 | $60,718 | View SEC filing | |
| 2025-12-04 | McGuire Annie SVP, General Counsel | Sale | -1,422 | -1.78%78,499 | $47.30 | $67,261 | View SEC filing | |
| 2025-12-04 | Chambers Rebecca Chief Financial Officer | Sale | -13,278 | -10.81%109,496 | $46.84 | $621,955 | View SEC filing | |
| 2025-12-04 | Stapley Marc Chief Executive Officer | Sale | -7,668 | -2.35%318,603 | $47.09 | $361,076 | View SEC filing | |
| 2025-11-26 | Leite John Chief Commercial Officer-CLIA | Sale | -2,808 | -3.15%86,291 | $50.00 | $140,400 | View SEC filing | |
| 2025-11-26 | JONES EVAN/ FA Director | Sale | -1,106 | -3.63%29,362 | $50.25 | $55,576 | View SEC filing | |
| 2025-11-21 | Holstein Jens Director | Sale | -10,000 | -26.88%27,199 | $42.36 | $423,563 | View SEC filing | |
| 2025-11-12 | Wygant Jonathan VP, Chief Accounting Officer | Sale | -10,920 | -21.99%38,745 | $41.20 | $449,907 | View SEC filing | |
| 2025-11-07 | McGuire Annie SVP, General Counsel | Sale | -6,466 | -7.23%82,973 | $40.00 | $258,640 | View SEC filing | |
| 2025-11-07 | Chambers Rebecca Chief Financial Officer | Sale | -7,000 | -5.26%126,158 | $41.00 | $287,000 | View SEC filing | |
| 2025-11-07 | EASTHAM KARIN Director | Sale | -9,674 | -41.65%13,554 | $40.02 | $387,191 | View SEC filing |
1-25 of 221
